A CJC-1295 and Ipamorelin bacteriostatic water mix is a laboratory-prepared aqueous solution containing the GHRH analog CJC-1295 and the selective growth hormone secretagogue Ipamorelin, dissolved in sterile 0.9% benzyl alcohol preserved water. This diluent provides a stable, sterile medium required for multi-dose sampling in preclinical somatotrophic signaling and cellular repair research.
A CJC-1295 and Ipamorelin bacteriostatic water mix is a laboratory-prepared aqueous solution containing the GHRH analog CJC-1295 and the selective growth hormone secretagogue Ipamorelin, dissolved in sterile 0.9% benzyl alcohol preserved water. This diluent provides a stable, sterile medium required for multi-dose sampling in preclinical somatotrophic signaling and cellular repair research.
In laboratory research settings, combining CJC-1295 (a synthetically modified growth hormone-releasing hormone analog) and Ipamorelin (a selective ghrelin/growth hormone secretagogue receptor agonist) requires a preserved, sterile solvent. Bacteriostatic water—composed of USP-grade sterile water for injection with 0.9% (9 mg/mL) benzyl alcohol—serves as the standard reconstituting agent. The inclusion of benzyl alcohol acts as a bacteriostatic inhibitor, preventing the proliferation of micro-organisms during repeated syringe insertions throughout multi-day experimental trials.
Lyophilized peptide complexes remain biologically dormant and thermally stable in solid matrix form. However, once researchers introduce bacteriostatic water, the peptides enter a dissolved, liquid state where chemical degradation pathways (such as hydrolysis, oxidation, and deamidation) become active. Understanding the stoichiometry, dissolution velocity, and temperature-dependent decay kinetics of this dual-peptide combination is vital for maintaining experimental reproducibility across cell culture assays and animal models.
CJC-1295 functions primary as a long-acting growth hormone-releasing hormone (GHRH) analog. By binding selectively to the GHRH receptor (GHRHR) on anterior pituitary somatotrophs, CJC-1295 stimulates the Gs-alpha protein subunit, activating adenylyl cyclase and elevating intracellular cyclic adenosine monophosphate (cAMP). This signal cascade drives both the transcription and exocytosis of growth hormone (GH). In preclinical research, CJC-1295 is evaluated for its capacity to sustain elevated baseline GH and downstream insulin-like growth factor 1 (IGF-1) levels, making it a key candidate for tissue repair research and metabolic signaling assays.
Conversely, Ipamorelin operates through a distinct, complementary pathway. As a pentapeptide agonist targeting the growth hormone secretagogue receptor (GHS-R1a, or ghrelin receptor), Ipamorelin triggers the phospholipase C (PLC) pathway, leading to inositol trisphosphate (IP3)-mediated calcium release from the sarcoplasmic/endoplasmic reticulum. Unlike earlier growth hormone-releasing peptides (GHRPs), preclinical trials demonstrate that Ipamorelin exhibits high receptor selectivity, inducing GH secretion without causing concomitant elevations in adrenocorticotropic hormone (ACTH), cortisol, or prolactin.
When combined in laboratory protocols, these two compounds demonstrate dual-pathway secretagogue synergism. While CJC-1295 amplifies the baseline signal and sustained release amplitude of GH via cAMP elevation, Ipamorelin induces a targeted, pulse-like influx of intracellular calcium. Preclinical rodent models indicate that co-administration yields a supra-additive growth hormone output compared to single-agent administration, offering researchers a robust model for investigating somatotrophic activity, collagen synthesis, and cell proliferation mechanisms.
The selection of the liquid diluent directly determines the chemical stability and biological viability of a reconstituted peptide solution. While plain sterile water (sterile water for injection without preservatives) is suitable for single-use applications, it lacks antimicrobial protection. Opening a single-use vial or drawing multiple aliquots from a non-preserved container introduces airborne microbes, leading to rapid contamination and enzymatic peptide degradation.
Bacteriostatic water contains 0.9% benzyl alcohol, which functions by disrupting bacterial cell membranes without altering the primary peptide structure or altering hydrogen bonding patterns required for receptor binding. This makes bacteriostatic water the standard vehicle for multi-dose experimental assays spanning up to 28 days when stored under controlled refrigeration (2°C to 8°C). Researchers must ensure that the pH of the reconstituted solution remains within a neutral-to-slightly-acidic range (pH 5.0 to 7.0) to prevent accelerated peptide hydrolysis.
For specialized laboratory assays where benzyl alcohol might interfere with sensitive cell cultures, researchers often opt for specialized buffer solutions or single-use sterile water. However, for general research peptides evaluated in multi-aliquot protocols, bacteriostatic water remains the standard reconstituting agent.
Achieving consistent concentration accuracy during reconstitution is essential for reproducible research. Lyophilized peptides are supplied in vacuum-sealed glass vials, often containing pre-blended quantities (e.g., 5 mg CJC-1295 combined with 5 mg Ipamorelin, or individual 2 mg/5 mg vials designed for target ratio co-reconstitution).
To calculate the concentration per volume unit ($ \text{Concentration} = \frac{\text{Mass of Peptide (mg)}}{\text{Volume of Diluent (mL)}} $), researchers match the intended microgram-per-microliter target to the precision limits of their volumetric pipettes or micro-syringes. For instance, dissolving a 10 mg total peptide cake (5 mg CJC-1295 + 5 mg Ipamorelin) in 2.0 mL of bacteriostatic water yields a final concentration of 5.0 mg/mL total peptide (2.5 mg/mL per individual active compound). In this scenario, every 0.1 mL (100 µL) drawn delivers 250 µg of each constituent compound.
Proper reconstitution technique mandates equalizing pressure and minimizing mechanical shear stress. The standard laboratory procedure involves the following steps:
1. Sanitize the rubber septa of both the bacteriostatic water and the peptide vial using 70% isopropyl alcohol wipes in a certified laminar flow hood.
2. Draw the measured volume of bacteriostatic water using a sterile syringe.
3. Aim the needle against the internal glass wall of the peptide vial rather than spraying directly onto the lyophilized cake to prevent high-velocity shear stress.
4. Allow the diluent to slowly flow down the wall, equalizing internal vial pressure if necessary.
5. Gently swirl the vial in a circular motion until the cake is fully dissolved. Never shake the vial, as physical agitation introduces air bubbles and induces protein aggregation or tertiary structure denaturation.
Lyophilized CJC-1295 and Ipamorelin exhibit high water solubility due to their polar amino acid sequences and hydrophilic side chains. Upon contact with bacteriostatic water, complete dissolution typically occurs within 30 to 120 seconds at ambient room temperature (20°C to 22°C).
Following reconstitution, the solution must undergo visual inspection under direct illumination against a dark backdrop. A fully dissolved, high-purity peptide solution appears entirely clear, colorless, and free of visible particulates, cloudiness, or fibrillar aggregates. Persistent turbidity or undissolved micro-particles indicate either incomplete dissolution, improper storage history, hydrophobic aggregation, or secondary salt precipitation.
If dissolution is delayed, allowing the vial to rest at room temperature for 5 to 10 minutes usually resolves the issue. Researchers should avoid applying heat or ultrasonic bath agitation, as thermal energy and acoustic shear force can cleave peptide bonds or accelerate side-chain oxidation.
Peptides are dynamic chemical entities subject to thermodynamic decay over time. In their lyophilized state, stored at -20°C to -80°C in a moisture-free environment, CJC-1295 and Ipamorelin maintain structural integrity for 24 to 36 months. However, once reconstituted in a cjc 1295 ipamorelin bacteriostatic water mix, the presence of water initiates chemical degradation pathways.
The primary mechanisms of peptide degradation in aqueous solution include:
• Hydrolysis: Cleavage of the peptide backbone, particularly sensitive at aspartic acid and glycine junctions.
• Oxidation: Modification of susceptible amino acid residues (such as methionine or tryptophan) exposed to dissolved oxygen.
• Deamidation: Conversion of asparagine and glutamine side chains into aspartic and glutamic acid, altering overall net charge and receptor affinity.
• Aggregation: Physical association of individual peptide chains forming biological inactive dimers or high-molecular-weight oligomers.
To mitigate these degradation rates, reconstituted vials must be stored in the dark under strict refrigeration between 2°C and 8°C. Under these conditions, the 0.9% benzyl alcohol preservative prevents microbial expansion, and structural integrity is maintained for up to 28 days. Freezing reconstituted peptide solutions is strongly discouraged; repeated freeze-thaw cycles cause cryo-concentration, phase separation, and mechanical cleavage of peptide chains caused by ice crystal propagation.
In vitro and animal model protocols utilize CJC-1295 and Ipamorelin to investigate the physiological downstream effects of pulsatile versus sustained growth hormone signaling. Because growth hormone plays a pivotal role in cellular metabolism, nitrogen retention, and extracellular matrix deposition, researchers utilize this secretagogue combination across several preclinical models:
• Tissue Repair and Wound Healing: Preclinical rodent models indicate that sustained GH and downstream IGF-1 elevation accelerates fibroblast migration, collagen deposition, and localized angiogenesis following skeletal muscle or tendon micro-trauma.
• Body Composition and Lipid Oxidation: In vivo rodent assays demonstrate that dual activation of GHRHR and GHS-R1a enhances lipolysis in white adipose tissue while promoting protein synthesis in skeletal muscle tissue.
• Bone Mineral Density: In vitro osteoblast culture models suggest that somatotrophic axis stimulation upregulates osteocalcin secretion and accelerates mineral matrix deposition.
• Pituitary Receptor Desensitization Kinetics: Researchers analyze continuous versus intermittent exposure of GHRHR and GHS-R1a to assess receptor downregulation, internalizing dynamics, and refractory period duration. Detailed mechanistic breakdowns can be explored through our growth hormone secretagogues overview.
When designing preclinical assays targeting somatotrophic output, researchers often evaluate several secretagogue combinations to determine optimal kinetic profiles. Comparing CJC-1295 and Ipamorelin against alternative analogs like Tesamorelin or Sermorelin highlights critical differences in half-life, receptor affinity, and pulse architecture.
The table below details the comparative biochemical profiles of primary secretagogues evaluated in preclinical somatotrophic research:
The reliability of preclinical data depends entirely on the chemical purity and structural integrity of the research peptides used. Unpurified or improperly synthesized peptides introduce unaccounted variables, such as truncated sequence impurities, residual trifluoroacetic acid (TFA) salts, and bacterial endotoxins, which can invalidate cell culture viability and induce non-specific inflammatory responses in animal models.
To guarantee experimental consistency, laboratory researchers must verify that their peptide suppliers adhere to stringent analytical quality control standards:
• High-Performance Liquid Chromatography (RP-HPLC): Reverse-phase HPLC establishes chemical purity. High-grade research compounds must yield a single, sharp chromatogram peak representing ≥98% purity, confirming the absence of truncated or deleted peptide sequences.
• Mass Spectrometry (ESI-MS / MALDI-TOF): Electrospray ionization mass spectrometry verifies the precise molecular weight of both CJC-1295 and Ipamorelin, ensuring exact amino acid sequence fidelity.
• Endotoxin Quantitation (LAL Testing): Bacterial endotoxins (lipopolysaccharides) alter cellular responses and provoke immunogenic reactions in vivo. Research-grade peptides must pass Limulus Amebocyte Lysate testing to confirm endotoxin levels remain strictly under <0.01 EU/mg.
• Manufactured in US Facilities: Products synthesized and packaged within ISO 17025-accredited and GMP-compliant USA laboratories guarantee lot-to-lot consistency and strict environmental control.
Every batch offered through PX1 Research comes accompanied by a lot-specific Certificate of Analysis (COA), featuring full RP-HPLC chromatograms and mass spectrometry raw data. High-volume research laboratories can also access custom volume terms through our wholesale lab portal.
What is the recommended volume of bacteriostatic water for mixing CJC-1295 and Ipamorelin?
The precise volume of bacteriostatic water depends on the targeted experimental concentration. Standard laboratory protocols typically utilize 1.0 mL to 2.0 mL of diluent per vial containing 5 mg to 10 mg of total combined peptide. Adding 2.0 mL of bacteriostatic water to a 5 mg/5 mg blend yields a clean, easily calculable concentration of 2.5 mg/mL per compound (5.0 mg/mL total peptide concentration).
Why is bacteriostatic water preferred over sterile saline or plain sterile water?
Bacteriostatic water contains 0.9% benzyl alcohol, an effective agent that prevents bacterial growth during repeated multi-dose draws over a 28-day window. Plain sterile water lacks preservatives, making it susceptible to rapid microbial contamination once opened. Normal saline (0.9% NaCl) can alter ionic strength and may cause localized peptide aggregation or precipitation depending on the specific isoelectric point of the peptide sequence.
How long does a reconstituted CJC-1295 Ipamorelin mix remain stable under refrigeration?
When reconstituted in bacteriostatic water (0.9% benzyl alcohol) and stored under strict refrigeration at 2°C to 8°C (36°F to 46°F), the solution maintains biological activity and structural integrity for up to 28 days. Protect the vial from light exposure and minimize physical shaking to prevent premature hydrolysis or oxidation.
Can you freeze a CJC-1295 and Ipamorelin solution after it has been reconstituted?
Freezing reconstituted peptide solutions is not recommended. Ice crystal formation during the freezing process causes mechanical stress that breaks delicate peptide bonds and alters secondary structures. Furthermore, the freezing process can cause benzyl alcohol to separate or cryo-concentrate, degrading the peptides. Lyophilized (un-reconstituted) powders, however, can be safely stored at -20°C to -80°C for extended periods.
What indicates that a reconstituted peptide mix has degraded or been contaminated?
Signs of chemical degradation or microbial contamination include permanent cloudiness, persistent discoloration, visible floating particulates, or severe solution turbidity that does not clear after resting at room temperature. Any reconstituted solution exhibiting these characteristics should be discarded immediately according to standard laboratory safety protocols.
What is the primary mechanistic difference between CJC-1295 with DAC and CJC-1295 without DAC?
CJC-1295 with DAC (Drug Affinity Complex) includes an added lysine linker bound to a maleimide group that covalently attaches to circulating blood albumin in vivo, extending its biological half-life to approximately 6 to 8 days. CJC-1295 without DAC (often referred to as Modified GRF 1-29) lacks this complex, resulting in a much shorter half-life of roughly 30 minutes. This shorter half-life allows researchers to mimic natural, pulsatile growth hormone release when co-administered with Ipamorelin.
How does PX1 Research ensure the purity and endotoxin compliance of its peptide supply?
PX1 Research subjects every production lot to independent third-party analytical testing. High-Performance Liquid Chromatography (RP-HPLC) verifies sequence purity above 98%, Mass Spectrometry confirms correct molecular weight, and LAL assays ensure endotoxin levels remain below strictly monitored research thresholds (<0.01 EU/mg). Fully detailed, lot-traceable COAs are available for every item.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.